Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

PHASE3CompletedINTERVENTIONAL

Enrollment

608

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Sleep Initiation and Maintenance DisordersInsomnia

Interventions

DRUG

eplivanserin (SR46349)

oral administration

DRUG

placebo

oral administration

Trial Locations (3)

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Macquarie Park

Sanofi-Aventis, Laval